Javascript must be enabled to continue!
ANTIBIOTIC PROFILE OF BURKHOLDERIA CEPACIA IN TERTIARY CARE HOSPITAL, VADODARA, GUJARAT, INDIA.
View through CrossRef
Since the early 1980's, Burkholderia cepacia is emerged as a causative agent of opportunistic human infections.
Burkholderia cepacia (B. cepacia) is an opportunistic pathogen which causes severe infections in patients with underlying
diseases, such as cystic brosis (CF) or chronic granulomatous disease (CGD). B. cepacia causes nosocomial bloodstream infections in non-CF
patients with a mortality rate of 25%–64%. Several severe infections caused by B. cepacia have been reported in children e.g. sepsis, pneumonia,
CNS infections, and urinary tract infections. This prospective analysis was done in tertiary care hospital in Vadodara during the period of January -
June 2023. 17 non-duplicate Burkholderia cepacia were recovered from samples. Out of 17 Burkholderia cepacia isolates, 12 isolates are most
sensitive to Meropenem (70.59%), Ceftazidime (52.94%), Trimethoprim/Sulphamethoxazole (47.06%), Cefoperazone/ Sulbactam (29.41%),
Imipenem (23.53%), Minocyclin (23.53%), Piperacillin/Tazobactam (17.65%), Cefepime (17.65%), Ciprooxacin (17.65%), Levooxacin
(17.65%), Aztreonam (5.88%) and, Tigecycline (0%).
Title: ANTIBIOTIC PROFILE OF BURKHOLDERIA CEPACIA IN TERTIARY CARE HOSPITAL, VADODARA, GUJARAT, INDIA.
Description:
Since the early 1980's, Burkholderia cepacia is emerged as a causative agent of opportunistic human infections.
Burkholderia cepacia (B.
cepacia) is an opportunistic pathogen which causes severe infections in patients with underlying
diseases, such as cystic brosis (CF) or chronic granulomatous disease (CGD).
B.
cepacia causes nosocomial bloodstream infections in non-CF
patients with a mortality rate of 25%–64%.
Several severe infections caused by B.
cepacia have been reported in children e.
g.
sepsis, pneumonia,
CNS infections, and urinary tract infections.
This prospective analysis was done in tertiary care hospital in Vadodara during the period of January -
June 2023.
17 non-duplicate Burkholderia cepacia were recovered from samples.
Out of 17 Burkholderia cepacia isolates, 12 isolates are most
sensitive to Meropenem (70.
59%), Ceftazidime (52.
94%), Trimethoprim/Sulphamethoxazole (47.
06%), Cefoperazone/ Sulbactam (29.
41%),
Imipenem (23.
53%), Minocyclin (23.
53%), Piperacillin/Tazobactam (17.
65%), Cefepime (17.
65%), Ciprooxacin (17.
65%), Levooxacin
(17.
65%), Aztreonam (5.
88%) and, Tigecycline (0%).
Related Results
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Isolation and characterization of bacteriophages against Burkholderia species
Isolation and characterization of bacteriophages against Burkholderia species
Abstract
Burkholderia cepacia complex (Bcc) is a potent nosocomial pathogen mainly encountered in immunocompromised, cystic fibrosis and chronic granulomatous patients. The...
Sequence and Structure-Based Classification of PenA β-Lactamase from Burkholderia stabilis
Sequence and Structure-Based Classification of PenA β-Lactamase from Burkholderia stabilis
The process of hydrolysis of the bond between amides of the four-membered β-lactam ring in Gram-negative bacteria is the key mechanism of resistance in β-lactamase enzymes. Because...
1711. In Vitro Activity of Cefiderocol Against US Achromobacter spp. and Burkholderia spp. Clinical Isolates from the SENTRY Surveillance Program 2020-2021
1711. In Vitro Activity of Cefiderocol Against US Achromobacter spp. and Burkholderia spp. Clinical Isolates from the SENTRY Surveillance Program 2020-2021
Abstract
Background
Infections caused by Achromobacter spp. and Burkholderia spp. have limited clinical treatment options due to...
Burkholderia humisilvae sp. nov., Burkholderia solisilvae sp. nov. and Burkholderia rhizosphaerae sp. nov., isolated from forest soil and rhizosphere soil
Burkholderia humisilvae sp. nov., Burkholderia solisilvae sp. nov. and Burkholderia rhizosphaerae sp. nov., isolated from forest soil and rhizosphere soil
Strains Y-12T and Y-47T were isolated from mountain forest soil and strain WR43T was isolated from rhizosphere soil, at Daejeon, Korea. The three strains grew at 10–55 °C (optimal ...
Association between Awareness on Antibiotic Resistance and Antibiotic Misuse Among Saudi University Students
Association between Awareness on Antibiotic Resistance and Antibiotic Misuse Among Saudi University Students
Background:
Saudi Arabia has the highest prevalence of resistant pathogens in the Gulf Region, with a rapid increase in antibiotic resistance seen in recent years. ...
A Case Report of CultureNegative Burkholderia Prosthetic Valve Endocarditis Identified by Metagenomic NextGeneration Sequencing (mNGS)
A Case Report of CultureNegative Burkholderia Prosthetic Valve Endocarditis Identified by Metagenomic NextGeneration Sequencing (mNGS)
Burkholderia cepacia complex is a group of closely related opportunistic Gram-negative species that can be found in soil and water. Burkholderia cepacia complex is commonly associa...
Why Do Indians Experience Less Happiness Than Pakistanis?
Why Do Indians Experience Less Happiness Than Pakistanis?
This study explores the enigma of happiness inequality between India and Pakistan, despite India’s economic prowess. Employing inequality regression models, the study pinpoints cru...

